This list is an analysis based on recent market events. It's not an investment recommendation.
Precision Biosensor, Inc. engages in the development, production, and sale of immune diagnostic kits in South Korea. It offers Exdia TRF Plus, an immunodiagnosis POCT platform; and Exdia PT10 and Exdia PT10S, a clinical chemistry POCT platform. The company was founded in 2009 and is headquartered in Daejeon, South Korea.
FAQs
What is Precision Biosensor stock price today?▼
The current price of 335810.KQ is ₩1,440 KRW — it has increased by +3.6% in the past 24 hours. Watch Precision Biosensor stock price performance more closely on the chart.
What is Precision Biosensor stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Precision Biosensor stocks are traded under the ticker 335810.KQ.
Is Precision Biosensor stock price growing?▼
335810.KQ stock has fallen by -0.48% compared to the previous week, the month change is a -3.1% fall, over the last year Precision Biosensor has showed a -50.34% decrease.
What is Precision Biosensor market cap?▼
Today Precision Biosensor has the market capitalization of 25.86B
What is Precision Biosensor revenue for the last year?▼
Precision Biosensor revenue for the last year amounts to 19.93B KRW.
What is Precision Biosensor net income for the last year?▼
335810.KQ net income for the last year is -10.02B KRW.
How many employees does Precision Biosensor have?▼
As of November 3, 2026, the company has 98 employees.
In which sector is Precision Biosensor located?▼
Precision Biosensor operates in the Energy sector.
When did Precision Biosensor complete a stock split?▼
Precision Biosensor has not had any recent stock splits.
Where is Precision Biosensor headquartered?▼
Precision Biosensor is headquartered in Daejeon, South Korea.